Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation

M. Zabel, C. Sticherling, R. Willems, A. Lubinski, A. Bauer, L. Bergau, F. Braunschweig, J. Brugada, S. Brusich, D. Conen, I. Cygankiewicz, P. Flevari, M. Taborsky, J. Hansen, G. Hasenfuß, R. Hatala, HV. Huikuri, S. Iovev, S. Kääb, G. Kaliska,...

. 2019 ; 6 (1) : 182-193. [pub] 20181009

Language English Country England, Great Britain

Document type Comparative Study, Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19012287

AIMS: The clinical effectiveness of primary prevention implantable cardioverter defibrillator (ICD) therapy is under debate. The EUropean Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators (EU-CERT-ICD) aims to assess its current clinical value. METHODS AND RESULTS: The EU-CERT-ICD is a prospective investigator-initiated non-randomized, controlled, multicentre observational cohort study performed in 44 centres across 15 European Union countries. We will recruit 2250 patients with ischaemic or dilated cardiomyopathy and a guideline indication for primary prophylactic ICD implantation. This sample will include 1500 patients at their first ICD implantation and 750 patients who did not receive a primary prevention ICD despite having an indication for it (non-randomized control group). The primary endpoint is all-cause mortality; the co-primary endpoint in ICD patients is time to first appropriate shock. Secondary endpoints include sudden cardiac death, first inappropriate shock, any ICD shock, arrhythmogenic syncope, revision procedures, quality of life, and cost-effectiveness. At baseline (and prior to ICD implantation if applicable), all patients undergo 12-lead electrocardiogram (ECG) and Holter ECG analysis using multiple advanced methods for risk stratification as well as detailed documentation of clinical characteristics and laboratory values. Genetic biobanking is also organized. As of August 2018, baseline data of 2265 patients are complete. All subjects will be followed for up to 4.5 years. CONCLUSIONS: The EU-CERT-ICD study will provide a necessary update about clinical effectiveness of primary prophylactic ICD implantation. This study also aims for improved risk stratification and patient selection using clinical and ECG risk markers.

2nd Department of Cardiology Attikon University Hospital Athens Greece

Chair and Department of Cardiology Bieganski Hospital Medical University of Lodz Lodz Poland

Department of Cardiology Acibadem City Clinic Tokuda Hospital Sofia Bulgaria

Department of Cardiology and Pneumology Heart Center University Medical Center Göttingen Germany

Department of Cardiology and Pneumology Heart Center University Medical Center Göttingen Germany DZHK partner site Göttingen Göttingen Germany

Department of Cardiology Karolinska Institutet Stockholm Sweden

Department of Cardiology KBC Sestre Milosrdnice Zagreb Croatia

Department of Cardiology Klinikum Großhadern Ludwig Maximilians Universität Munich Munich Germany

Department of Cardiology Magdalena Klinika Krapinske Toplice Croatia

Department of Cardiology Medical University of Lodz WAM Hospital Lodz Poland

Department of Cardiology National Heart Hospital Sofia Bulgaria

Department of Cardiology Semmelweis University Heart Center Budapest Hungary

Department of Cardiology St Anna Hospital Sofia Bulgaria

Department of Cardiology St Ekaterina University Hospital Sofia Bulgaria

Department of Cardiology SUSSCH Banska Bystrica Slovakia

Department of Cardiology The Heart Centre Rigshospitalet Copenhagen University Hospital and Department of Clinical Medicine University of Copenhagen Copenhagen Denmark

Department of Cardiology University Hospital Basel Switzerland

Department of Cardiology University Hospital Basel Switzerland Population Health Research Institute McMaster University Hamilton ON Canada

Department of Cardiology University Hospital Olomouc Czech Republic

Department of Cardiology University Medical Center Utrecht Utrecht The Netherlands

Department of Cardiovascular Disease KBC Rijeka Rijeka Croatia

Department of Cardiovascular Sciences University of Leuven Belgium

Department of Electrocardiology Medical University of Lodz Lodz Poland

Department of Internal Medicine and Cardiology University Hospital Brno Brno Czech Republic

Department of Medical Physiology University Medical Center Utrecht Utrecht The Netherlands

DZHK partner site Göttingen Göttingen Germany Department of Medical Statistics University Medical Center Göttingen Göttingen Germany

Gentofte Hospital Copenhagen Denmark

IDIBAPS Department of Cardiology Hospital Clinic Barcelona Barcelona Spain

Institute for Social Medicine Epidemiology and Health Economics Charité Universitätsmedizin Berlin Berlin Germany

Med Klinik und Poliklinik 1 Technische Universität München Klinikum rechts der Isar Munich Germany

Medical Research Center Oulu University Hospital and University of Oulu Oulu Finland

National Heart and Lung Institute Imperial College London UK

Slovak Medical University NUSCH Bratislava Slovakia

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012287
003      
CZ-PrNML
005      
20250610100040.0
007      
ta
008      
190405s2019 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ehf2.12367 $2 doi
035    __
$a (PubMed)30299600
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Zabel, Markus $u Department of Cardiology and Pneumology, Heart Center, University Medical Center, Göttingen, Germany. DZHK (German Center for Cardiovascular Research), partner site Göttingen, Göttingen, Germany.
245    10
$a Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation / $c M. Zabel, C. Sticherling, R. Willems, A. Lubinski, A. Bauer, L. Bergau, F. Braunschweig, J. Brugada, S. Brusich, D. Conen, I. Cygankiewicz, P. Flevari, M. Taborsky, J. Hansen, G. Hasenfuß, R. Hatala, HV. Huikuri, S. Iovev, S. Kääb, G. Kaliska, JD. Kasprzak, L. Lüthje, M. Malik, T. Novotny, N. Pavlović, G. Schmidt, T. Shalganov, R. Sritharan, S. Schlögl, J. Szavits Nossan, V. Traykov, AE. Tuinenburg, V. Velchev, MA. Vos, SN. Willich, T. Friede, JH. Svendsen, B. Merkely, . ,
520    9_
$a AIMS: The clinical effectiveness of primary prevention implantable cardioverter defibrillator (ICD) therapy is under debate. The EUropean Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators (EU-CERT-ICD) aims to assess its current clinical value. METHODS AND RESULTS: The EU-CERT-ICD is a prospective investigator-initiated non-randomized, controlled, multicentre observational cohort study performed in 44 centres across 15 European Union countries. We will recruit 2250 patients with ischaemic or dilated cardiomyopathy and a guideline indication for primary prophylactic ICD implantation. This sample will include 1500 patients at their first ICD implantation and 750 patients who did not receive a primary prevention ICD despite having an indication for it (non-randomized control group). The primary endpoint is all-cause mortality; the co-primary endpoint in ICD patients is time to first appropriate shock. Secondary endpoints include sudden cardiac death, first inappropriate shock, any ICD shock, arrhythmogenic syncope, revision procedures, quality of life, and cost-effectiveness. At baseline (and prior to ICD implantation if applicable), all patients undergo 12-lead electrocardiogram (ECG) and Holter ECG analysis using multiple advanced methods for risk stratification as well as detailed documentation of clinical characteristics and laboratory values. Genetic biobanking is also organized. As of August 2018, baseline data of 2265 patients are complete. All subjects will be followed for up to 4.5 years. CONCLUSIONS: The EU-CERT-ICD study will provide a necessary update about clinical effectiveness of primary prophylactic ICD implantation. This study also aims for improved risk stratification and patient selection using clinical and ECG risk markers.
650    _2
$a dilatační kardiomyopatie $x komplikace $x mortalita $x terapie $7 D002311
650    _2
$a náhlá srdeční smrt $x epidemiologie $x etiologie $x prevence a kontrola $7 D016757
650    12
$a defibrilátory implantabilní $7 D017147
650    _2
$a elektrokardiografie $7 D004562
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a výběr pacientů $7 D018579
650    _2
$a primární prevence $x metody $7 D011322
650    _2
$a prospektivní studie $7 D011446
650    _2
$a kvalita života $7 D011788
650    12
$a hodnocení rizik $7 D018570
650    _2
$a míra přežití $x trendy $7 D015996
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sticherling, Christian $u Department of Cardiology, University Hospital, Basel, Switzerland.
700    1_
$a Willems, Rik $u Department of Cardiovascular Sciences, University of Leuven, Belgium.
700    1_
$a Lubinski, Andrzej $u Department of Cardiology, Medical University of Lodz (MUL) WAM Hospital, Lodz, Poland.
700    1_
$a Bauer, Axel $u Department of Cardiology, Klinikum Großhadern, Ludwig-Maximilians-Universität Munich, Munich, Germany.
700    1_
$a Bergau, Leonard $u Department of Cardiology and Pneumology, Heart Center, University Medical Center, Göttingen, Germany.
700    1_
$a Braunschweig, Frieder $u Department of Cardiology, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Brugada, Josep $u IDIBAPS, Department of Cardiology, Hospital Clinic Barcelona, Barcelona, Spain.
700    1_
$a Brusich, Sandro $u Department of Cardiovascular Disease, KBC Rijeka, Rijeka, Croatia.
700    1_
$a Conen, David $u Department of Cardiology, University Hospital, Basel, Switzerland. Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
700    1_
$a Cygankiewicz, Iwona $u Department of Electrocardiology, Medical University of Lodz (MUL), Lodz, Poland.
700    1_
$a Flevari, Panagiota $u 2nd Department of Cardiology, Attikon University Hospital, Athens, Greece.
700    1_
$a Taborsky, Milos $u Department of Cardiology, University Hospital, Olomouc, Czech Republic.
700    1_
$a Hansen, Jim $u Gentofte Hospital, Copenhagen, Denmark.
700    1_
$a Hasenfuß, Gerd $u Department of Cardiology and Pneumology, Heart Center, University Medical Center, Göttingen, Germany. DZHK (German Center for Cardiovascular Research), partner site Göttingen, Göttingen, Germany.
700    1_
$a Hatala, Robert $u Slovak Medical University NUSCH, Bratislava, Slovakia.
700    1_
$a Huikuri, Heikki V $u Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland.
700    1_
$a Iovev, Svetoslav $u Department of Cardiology, St. Ekaterina University Hospital, Sofia, Bulgaria.
700    1_
$a Kääb, Stefan $u Department of Cardiology, Klinikum Großhadern, Ludwig-Maximilians-Universität Munich, Munich, Germany.
700    1_
$a Kaliska, Gabriela $u Department of Cardiology, SUSSCH, Banska Bystrica, Slovakia.
700    1_
$a Kasprzak, Jaroslaw D $u Chair and Department of Cardiology, Bieganski Hospital, Medical University of Lodz (MUL), Lodz, Poland.
700    1_
$a Lüthje, Lars $u Department of Cardiology and Pneumology, Heart Center, University Medical Center, Göttingen, Germany.
700    1_
$a Malik, Marek $u National Heart and Lung Institute, Imperial College, London, UK.
700    1_
$a Novotný, Tomáš, $d 1969- $u Department of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czech Republic. $7 xx0055126
700    1_
$a Pavlović, Nikola $u Department of Cardiology, KBC Sestre Milosrdnice, Zagreb, Croatia.
700    1_
$a Schmidt, Georg $u Med. Klinik und Poliklinik I, Technische Universität München, Klinikum rechts der Isar, Munich, Germany.
700    1_
$a Shalganov, Tchavdar $u Department of Cardiology, National Heart Hospital, Sofia, Bulgaria.
700    1_
$a Sritharan, Rajeeva $u Department of Cardiology and Pneumology, Heart Center, University Medical Center, Göttingen, Germany.
700    1_
$a Schlögl, Simon $u Department of Cardiology and Pneumology, Heart Center, University Medical Center, Göttingen, Germany.
700    1_
$a Szavits Nossan, Janko $u Department of Cardiology, Magdalena Klinika, Krapinske Toplice, Croatia.
700    1_
$a Traykov, Vassil $u Department of Cardiology, Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria.
700    1_
$a Tuinenburg, Anton E $u Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
700    1_
$a Velchev, Vasil $u Department of Cardiology, St. Anna Hospital, Sofia, Bulgaria.
700    1_
$a Vos, Marc A $u Department of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands.
700    1_
$a Willich, Stefan N $u Institute for Social Medicine, Epidemiology and Health Economics, Charité Universitätsmedizin Berlin, Berlin, Germany.
700    1_
$a Friede, Tim $u DZHK (German Center for Cardiovascular Research), partner site Göttingen, Göttingen, Germany. Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
700    1_
$a Svendsen, Jesper Hastrup $u Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
700    1_
$a Merkely, Béla $u Department of Cardiology, Semmelweis University Heart Center, Budapest, Hungary.
700    1_
$a ,
773    0_
$w MED00197251 $t ESC heart failure $x 2055-5822 $g Roč. 6, č. 1 (2019), s. 182-193
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30299600 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20250610100033 $b ABA008
999    __
$a ok $b bmc $g 1391597 $s 1050592
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 6 $c 1 $d 182-193 $e 20181009 $i 2055-5822 $m ESC heart failure $n ESC Heart Fail $x MED00197251
LZP    __
$a Pubmed-20190405

Find record

Citation metrics

Archiving options